期刊
JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 31, 期 9, 页码 1037-1040出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2012.05.008
关键词
foscarnet; lung transplantation; cytomegalovirus; treatment; adverse event; precipitation; crystal nephropathy
资金
- Fondation Nuovo-Soldati
We present the case of a lung transplant recipient with disseminated crystal precipitation, and granulomatous and fibrinous inflammation after therapy with foscarnet (Foscavir; AstraZeneca, Zug, Switzerland) for recurring ganciclovir-resistant cytomegalovirus (CMV) reactivation. This is the first description of systemic crystal precipitation and granulomatous inflammation associated with foscarnet therapy with predominant involvement of the heart, kidneys and lungs. J Heart Lung Transplant 2012;31:1037-40 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据